PSEUDOCELL

The World Health Organization (WHO) on Wednesday endorsed the first malaria vaccine ‘ Mosquirix’ , which could prevent the deaths of tens of thousands of children a year.  To have a malaria vaccine that is safe, moderately effective and ready for distribution is “a historic event,” said Dr. Pedro Alonso, director of the WHO global malaria program.   The new vaccine, even with modest efficacy, is considered as the best new development in the battle against malaria in decades, some experts said.  Studies show that malaria kills about half a million people each year, nearly all of them in sub-Saharan Africa — including 260,000 children under 5.  The new vaccine, made by GlaxoSmithKline, rouses a child’s immune system to beat Plasmodium falciparum, the deadliest of five malarial pathogens and the most of which are prevalent in Africa. Mosquirix is given in three doses between ages 5 and 17 months, and a fourth dose roughly 18 months later.   Clinical trials shows that the GlaxoSmithKline v

Multisystem Inflammatory Syndrome in children (MIS-C) is a serious condition that appears to be linked to COVID-19.   Many cases of MISC have been reported in Uttar Pradesh. MIS-C reported to develops a month after recovery from Covid.  MIS-C is rare, and most children who have it eventually get better with medical care. But some kids rapidly get worse, to the point where their lives are at risk.  Doctors and researchers are still researching why some children develop this illness after COVID-19 infection but not others  . What is MIS-C ? MIS-C is a serious condition in which organs such as heart, lungs, kidneys, brain, skin, eyes or gastrointestinal organs get inflamed.  MIS-C usually affects school-age children, most commonly 8 and 9 years old. MIS-C symptoms appear between two and six weeks (four weeks on average) after COVID-19 infection.  The exact reasons behind MIS-C is still unknown, but at present, most cases are associated with Covid. At times, the antibodies developed durin

According to Vaccine Adverse Event Reporting System (VAERS), cases of myocarditis and pericarditis have been reported after mRNA COVID-19 vaccination (Pfizer-BioNTech or Moderna) especially in male adolescents and young adults. Usually symptoms appear within 7 days following the second dose of vaccination. What is Myocarditis?  Myocarditis is the inflammation of heart muscle, and pericarditis is inflammation of the outer lining of the heart. This inflammation can reduce the heart’s ability to pump blood around the body. In severe cases, myocarditis can cause blood clots to form. This could lead to serious conditions, such as heart attack, stroke, heart failure and even cardiac arrest. What to look out for after vaccination   In Adults Chest pain Shortness of breath Fast-beating, fluttering, or pounding heartbeat ( Palpitation ) Fatigue  Swelling of legs, ankles and feet In Children Fever Fainting episodes Difficulty in breathing Rapid breathing Rapid or abnormal heartbeats Can a COVID-

Data suggests that people are happy to work from home amidst the Covid 19 pandemic. While health care professionals are seeing rising cases of new or worsening neck, back and shoulder pain among young working adults.  “The prevalence    of Sick scapula syndrome, especially among IT professionals, reception and desk workers has surprisingly increased due to Work from Home (WFH) culture.” Normally, sportsperson have higher incidence of scapular dyskinesis of around 64 percent as compared with non-athletes.  However, work from home culture (WFH) with poor sitting posture or prolonged sitting without break, prolonged movement of muscles may strain the scapula and can led to dyskinesia among young working people. What is Sick Scapula Syndrome?   Sick scapula syndrome, also known as Scapular Dyskinesis, is the abnormal flexibility or deviation of the scapula (shoulder bone) during shoulder movement. The shoulder joint which is a ball-and-socket joint, is made up of the humerus (upper arm b

It is observed that there is an    increased risk of GBS following COVID 19 vaccination. WHO Global Advisory Committee on Vaccine Safety (GACVS) discusses rare reports of Guillain-Barré Syndrome (GBS) following vaccination with the Janssen and AstraZeneca COVID-19 vaccines.   GACVS Committee Conclusion Rare cases of GBS have been reported following vaccinations with adenovirus vector COVID-19 vaccines. Increased reports of GBS have not been observed following mRNA COVID-19 vaccines. Although they could not confirm nor rule out an association with the vaccine .  GBS will be listed as a very rare side effect of COVID-19 Vaccine Janssen.   Therefore warning is given to raise awareness among healthcare professionals and people taking the vaccine. What is Guillain-Barré syndrome (GBS) ? GBS is a rare, autoimmune disorder in which a person's own immune system damages the nerves , causing muscle weakness and sometimes paralysis. Symptoms Muscle weakness,  Difficulty in walking Weakness